APA (7th ed.) Citation

de Moraes, F. C. A., Pasqualotto, E., Chavez, M. P., Ferreira, R. O. M., De Castria, T. B., & Burbano, R. M. R. (2024). Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: A meta-analysis of randomized clinical trials. BMC Cancer, 24(1), 1. https://doi.org/10.1186/s12885-024-11980-w

Chicago Style (17th ed.) Citation

de Moraes, Francisco Cezar Aquino, Eric Pasqualotto, Matheus Pedrotti Chavez, Rafael Oliva Morgado Ferreira, Tiago Biachi De Castria, and Rommel Mario Rodríguez Burbano. "Efficacy and Safety of Zolbetuximab Plus Chemotherapy for Advanced CLDN18.2-positive Gastric or Gastro-oesophageal Adenocarcinoma: A Meta-analysis of Randomized Clinical Trials." BMC Cancer 24, no. 1 (2024): 1. https://doi.org/10.1186/s12885-024-11980-w.

MLA (9th ed.) Citation

de Moraes, Francisco Cezar Aquino, et al. "Efficacy and Safety of Zolbetuximab Plus Chemotherapy for Advanced CLDN18.2-positive Gastric or Gastro-oesophageal Adenocarcinoma: A Meta-analysis of Randomized Clinical Trials." BMC Cancer, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12885-024-11980-w.